With $120m jointly invested in the newly-formed initiative, and with other strategic investors expected to join, the venture will develop an alternative, plant-based ingredient using biotechnology
Revenues from operations for the full year ended March 31, 2022 stood at Rs. 590.05 crore as compared to Rs. 449.82 crore in FY21
Ganguly will execute company's strategic focus on leveraging CustomGlycan to develop novel therapeutics
TMA will leverage Syntegra's synthetic data engine to accelerate the building of predictive diagnostic algorithms
QIAGEN has started its cloud transformation journey with the firm belief that cloud computing can be a key enabler of future business growth
The innovative software module is designed to meet growing scientific demand from researchers and drug developers
The new program includes upstream and downstream process development and large-scale GMP production.
Centre of Excellence at Kharel comprises Skill-building Centre and Primary, Secondary and Higher Secondary schools
Marinus has broadened inclusion criteria in the RAISE trial to allow for enrollment of patients previously treated with IV anesthesia.
Bayer now present in four of the largest biotechnology hubs in the United States
Subscribe To Our Newsletter & Stay Updated
